499 related articles for article (PubMed ID: 33915501)
1. Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase.
Ahmed S; Khan ST; Zargaham MK; Khan AU; Khan S; Hussain A; Uddin J; Khan A; Al-Harrasi A
Biomed Pharmacother; 2021 Jul; 139():111609. PubMed ID: 33915501
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning.
Kabir MT; Uddin MS; Begum MM; Thangapandiyan S; Rahman MS; Aleya L; Mathew B; Ahmed M; Barreto GE; Ashraf GM
Curr Pharm Des; 2019; 25(33):3519-3535. PubMed ID: 31593530
[TBL] [Abstract][Full Text] [Related]
4. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
Sahoo AK; Dandapat J; Dash UC; Kanhar S
J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
[TBL] [Abstract][Full Text] [Related]
5. An insight into structure-activity relationship of naturally derived biological macromolecules for the treatment of Alzheimer's disease: a review.
Halder D; Das S; Joseph A
J Biomol Struct Dyn; 2024 Aug; 42(12):6455-6471. PubMed ID: 37378526
[TBL] [Abstract][Full Text] [Related]
6. Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.
Huang L; Su T; Li X
Curr Top Med Chem; 2013; 13(15):1864-78. PubMed ID: 23931437
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
Darreh-Shori T; Hosseini SM; Nordberg A
J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
9. A molecular approach in drug development for Alzheimer's disease.
Agatonovic-Kustrin S; Kettle C; Morton DW
Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
[TBL] [Abstract][Full Text] [Related]
10. Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.
Castro A; Martinez A
Mini Rev Med Chem; 2001 Sep; 1(3):267-72. PubMed ID: 12369973
[TBL] [Abstract][Full Text] [Related]
11. [Development of therapies for Alzheimer's disease based on cholinergic hypothesis-status quo and future directions].
Shimohama S
Rinsho Shinkeigaku; 2013; 53(11):1036-8. PubMed ID: 24291871
[TBL] [Abstract][Full Text] [Related]
12. Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.
Tuzimski T; Petruczynik A
Molecules; 2022 May; 27(10):. PubMed ID: 35630702
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
Musiał A; Bajda M; Malawska B
Curr Med Chem; 2007; 14(25):2654-79. PubMed ID: 17979717
[TBL] [Abstract][Full Text] [Related]
14. Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer's disease: an insight into structure-activity relationship.
Halder D; Das S; R S J; Joseph A
J Biomol Struct Dyn; 2023 Dec; 41(20):11286-11323. PubMed ID: 36579430
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibition in Alzheimer's Disease.
Ibach B; Haen E
Curr Pharm Des; 2004; 10(3):231-51. PubMed ID: 14754384
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase as a Target for Drug Development in Alzheimer's Disease.
Sharma P; Tripathi MK; Shrivastava SK
Methods Mol Biol; 2020; 2089():257-286. PubMed ID: 31773661
[TBL] [Abstract][Full Text] [Related]
17. From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease.
Pérez DI; Martínez A; Gil C; Campillo NE
Curr Med Chem; 2015; 22(33):3789-806. PubMed ID: 26264921
[TBL] [Abstract][Full Text] [Related]
18. Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?
Moss DE
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414155
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
20. Withanolides: Biologically Active Constituents in the Treatment of Alzheimer's Disease.
Khan SA; Khan SB; Shah Z; Asiri AM
Med Chem; 2016; 12(3):238-56. PubMed ID: 26527154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
